ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma.
about
RNA processing: a new player of genomic instability in multiple myeloma.Evolutionary biology of high-risk multiple myeloma.A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma.Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.
P2860
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@en
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@nl
type
label
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@en
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@nl
prefLabel
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@en
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@nl
P2093
P2860
P50
P1433
P1476
ILF2 Is a Regulator of RNA Spl ...... 21-Amplified Multiple Myeloma.
@en
P2093
Carlos Bueso-Ramos
Chang-Jiun Wu
Elena Fiorini
Giulio Draetta
Guillermo Garcia-Manero
Hagop Kantarjian
Karen Clise-Dwyer
Maria Teresa Fulciniti
P2860
P304
P356
10.1016/J.CCELL.2017.05.011
P50
P577
2017-06-29T00:00:00Z